Urinary Frequency More Than Once at Night
9
4
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)
UCon Treatment of Overactive Bladder (OAB) in Males
TEST-ON - Does iStim Reduce Urinary Urgency?
Safety and Performance of UCon Patch Electrode
Bladder Diary for Female Storage LUTS
Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A